ENEMAC FL 130ML 16.1+6/100ML

ENEMAC 16,1G/100ML+6G/100ML RECOVERNMENT

active ingredients

100 ml contain: Active ingredients: Monosodium phosphate 16,10 g Phosphate bisodium eptahydrate 6 g Excipients: Purified water F.U. q.b. Excipients with known effects: Methyl sodium p-hydroxybenzoate 0.104 g For full list of excipients, see paragraph 6.1.

Excellent

Sodium methyl p-hydroxybenzoate Purified Water F.U.

Therapeutic indications

Stitching. Intestinal evacuation before radiological examinations or other diagnostic tests.

Contraindications

Hypersensitivity to the active ingredient or any of the excipients listed in paragraph 6.1. Ano-rectal affections.

Population

Population He's only acting straight. Adults: 1 ENEMAC bottle per day. Children over 2 years: half or quarter of the adult dose. Do not exceed the recommended doses. Method of administration Push the hood down to the break of the safety seal of the bottle. Remove the protective cap from the rectal cannula. Lubricate the latter with a few drops of ENEMAC lying on the left side and introduce it gently into the rectum. Press the bottle to release the liquid and extract it while holding it. Keep the liquid in a coricated position until you feel urgently the need to evacuate (about 5 minutes): no more than 10-15 minutes.

Conservation

Store at a temperature below 30°C. Do not disperse in the environment. Store in ordinary environment conditions.

Warnings

In children over two years the cannula should not penetrate more than half the length. In the cold season it is recommended to bring the product to room temperature by heating to the bathroom. Use in occasional administrations. Do not use in children under two years of age except under medical supervision. Continuous use of laxatives can result in a different type of addiction or damage. Do not use laxatives if there are abdominal pain, nausea and vomiting. If constipation is stubborn, consult your doctor. Prolonged use can induce a dehydration state. The product contains sodium salts in the quantity indicated above; this shall be taken into account in the case of hypothetical dietary regime.

Interactions

Until now, interactions with other drugs have not been reported.

Effects

Prolonged use can induce a dehydration state. The patient is invited to communicate to his physician or pharmacist the occurrence of any unwanted effect that should appear in case of use. Reporting of suspicious adverse reactions The reporting of suspicious adverse reactions occurring after the authorization of the medicinal product is important, as it allows continuous monitoring of the benefit/risk ratio of the medicinal product. Healthcare workers are required to report any suspected adverse reaction via the national reporting system at the address http://www.agenziafarmaco.gov.it/it/responsabili.

Overdosing

No overdose accidents have been reported.

Use in pregnancy is not contraindicated.

Source: Farmadati